BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 36127469)

  • 21. Heterologous and rare homologous sarcomas of the uterine corpus: a clinicopathologic review.
    Fadare O
    Adv Anat Pathol; 2011 Jan; 18(1):60-74. PubMed ID: 21169739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overexpression of MyoD-inducible lysosomal sialidase (neu1) inhibits myogenesis in C2C12 cells.
    Champigny MJ; Perry R; Rudnicki M; Igdoura SA
    Exp Cell Res; 2005 Nov; 311(1):157-66. PubMed ID: 16216242
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The current landscape of rhabdomyosarcomas: an update.
    Leiner J; Le Loarer F
    Virchows Arch; 2020 Jan; 476(1):97-108. PubMed ID: 31696361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterization of a bladder pleomorphic rhabdomyosarcoma in an adult patient.
    Feroce F; Cantile M; Aquino G; Collina F; Scognamiglio G; Castaldo L; PerdonĂ  S; Botti G; De Chiara A
    Pathol Res Pract; 2020 Aug; 216(8):153033. PubMed ID: 32703497
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Excessive exosome release is the pathogenic pathway linking a lysosomal deficiency to generalized fibrosis.
    van de Vlekkert D; Demmers J; Nguyen XX; Campos Y; Machado E; Annunziata I; Hu H; Gomero E; Qiu X; Bongiovanni A; Feghali-Bostwick CA; d'Azzo A
    Sci Adv; 2019 Jul; 5(7):eaav3270. PubMed ID: 31328155
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New Insights into Molecular Organization of Human Neuraminidase-1: Transmembrane Topology and Dimerization Ability.
    Maurice P; Baud S; Bocharova OV; Bocharov EV; Kuznetsov AS; Kawecki C; Bocquet O; Romier B; Gorisse L; Ghirardi M; Duca L; Blaise S; Martiny L; Dauchez M; Efremov RG; Debelle L
    Sci Rep; 2016 Dec; 6():38363. PubMed ID: 27917893
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel Nile tilapia Neu1 sialidases: Molecular cloning and biochemical characterization of the sialidases Neu1a and Neu1b.
    Honda A; Chigwechokha PK; Takase R; Hayasaka O; Fujimura K; Kotani T; Komatsu M; Shiozaki K
    Gene; 2020 Jun; 742():144538. PubMed ID: 32184168
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic modeling of human rhabdomyosarcoma.
    Linardic CM; Downie DL; Qualman S; Bentley RC; Counter CM
    Cancer Res; 2005 Jun; 65(11):4490-5. PubMed ID: 15930263
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemical Characterization of Sarcomas in Trp53+/- Haploinsufficient Mice.
    Jokinen MP; Morgan DL; Price HC; Herbert RA; Saddler T; Dixon D
    Toxicol Pathol; 2017 Aug; 45(6):774-785. PubMed ID: 29046139
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells.
    Rao PK; Missiaglia E; Shields L; Hyde G; Yuan B; Shepherd CJ; Shipley J; Lodish HF
    FASEB J; 2010 Sep; 24(9):3427-37. PubMed ID: 20466878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of TLR4 Sialylation Mediated by a Sialidase Neu1 and Impairment of Its Signaling in
    Karmakar J; Roy S; Mandal C
    Front Immunol; 2019; 10():2360. PubMed ID: 31649671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biochemical and molecular characterization of novel mutations in GLB1 and NEU1 in patient cells with lysosomal storage disorders.
    Kwak JE; Son MY; Son YS; Son MJ; Cho YS
    Biochem Biophys Res Commun; 2015 Feb; 457(4):554-60. PubMed ID: 25600812
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Establishment and characterization of Neu1-knockout zebrafish and its abnormal clinical phenotypes.
    Okada K; Takase R; Hamaoka Y; Honda A; Ikeda A; Hokazono Y; Maeda Y; Hayasaka O; Kotani T; Komatsu M; Shiozaki K
    Biochem J; 2020 Aug; 477(15):2841-2857. PubMed ID: 32686823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Occurrence in brain lysosomes of a sialidase active on ganglioside.
    Fiorilli A; Venerando B; Siniscalco C; Monti E; Bresciani R; Caimi L; Preti A; Tettamanti G
    J Neurochem; 1989 Sep; 53(3):672-80. PubMed ID: 2760615
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cloning and characterization of a sialidase from the murine histocompatibility-2 complex: low levels of mRNA and a single amino acid mutation are responsible for reduced sialidase activity in mice carrying the Neu1a allele.
    Carrillo MB; Milner CM; Ball ST; Snoek M; Campbell RD
    Glycobiology; 1997 Oct; 7(7):975-86. PubMed ID: 9363440
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The diagnosis and classification of childhood rhabdomyosarcoma.
    Tsokos M
    Semin Diagn Pathol; 1994 Feb; 11(1):26-38. PubMed ID: 8202644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rhabdomyosarcoma in middle-aged and elderly individuals.
    Seidal T; Kindblom LG; Angervall L
    APMIS; 1989 Mar; 97(3):236-48. PubMed ID: 2713135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Integrative Morphologic and Molecular Approach for Diagnosis and Subclassification of Rhabdomyosarcoma.
    Fan R; Parham DM; Wang LL
    Arch Pathol Lab Med; 2022 Aug; 146(8):953-959. PubMed ID: 35051261
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The identification of lysosomal ganglioside sialidase in human cells.
    Zeigler M; Sury V; Bach G
    Eur J Biochem; 1989 Aug; 183(2):455-8. PubMed ID: 2759093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long non-coding RNA TOB1-AS1 modulates cell proliferation, apoptosis, migration and invasion through miR-23a/NEU1 axis via Wnt/b-catenin pathway in gastric cancer.
    Jiang K; Zhi XH; Ma YY; Zhou LQ
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9890-9899. PubMed ID: 31799657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.